What decision support should surface
Patient goals
Driving, night driving, computer work, reading, hobbies, desire for glasses independence, tolerance for halos, and willingness for follow-up visits.
Ocular risk
Irregular cornea, high HOA, ocular surface disease, glaucoma, macular disease, post-LASIK/PRK/RK status, and biometry repeatability.
Optical tradeoffs
Expected distance, intermediate, and near profile; dysphotopsia risk; contrast expectations; residual spectacle dependence; and enhancement possibility.
Documentation
Why the pathway fits, what was discussed, what requires verification, and which assumptions the surgeon accepted before surgery.
Market signal: premium IOLs are a workflow category
Recent premium IOL momentum from major manufacturers reinforces the need to compare more than brand names. Surgeons need a neutral way to discuss enhanced monofocal, EDOF, trifocal, toric, virtual-aperture, and adjustable pathways in terms of patient goals, dysphotopsia tolerance, residual refractive risk, visit burden, cost/access, and documentation.
Bausch + Lomb's ESCRS 2026 program is expected to include IOL outcomes, patient-reported outcomes, toric/full-range visual outcomes, and the impact of residual refractive error on visual acuity. That makes expectation-setting and residual-error tolerance a core part of premium IOL planning, not an afterthought.
September ESCRS coverage adds six practical counseling signals: post-LASIK premium IOL planning is becoming risk-stratified rather than automatically avoided; mesopic reading performance can matter more to patients than a distance-acuity snapshot; AI-designed optics plus patient simulation are becoming part of how premium lenses are explained; enhanced monofocal data is strengthening the middle ground for patients who may only need distance plus functional intermediate vision; the 2024 EUREQUO registry report highlights that advanced-lens access remains limited by cost even as cataract outcomes improve; and Z Optics' investigational Z+ release raises the question of whether virtual-aperture optics can deliver range without multifocal halos.
This is where PrecisionIOL should sit: not as a manufacturer ecosystem, and not as a black-box recommender, but as an explainable planning layer that helps the clinician review why one pathway may fit better than another. See the dedicated EDOF IOL planning guide for range-of-vision, halo, contrast, mesopic reading, and patient-fit counseling.
Lens pathways to compare
| Pathway | Best fit | Counseling emphasis |
|---|---|---|
| Monofocal / enhanced monofocal | Quality-first patients, night drivers, intermediate-task users, lower tolerance for optical symptoms | Target distance, functional intermediate expectations, near glasses, astigmatism plan |
| Toric | Meaningful regular astigmatism with reliable axis measurements | Axis confidence, residual cylinder, rotation risk |
| EDOF | Distance/intermediate priority, computer use, moderate desire for range | Near limitations, glare/halo possibility, contrast expectations |
| Multifocal / trifocal | High desire for range and glasses independence with healthy optics | Dysphotopsia, neuroadaptation, corneal/retinal screening |
| Virtual aperture / aperture-style | Patients who need range but are especially concerned about halos, glare, and mesopic performance | Currently a watchlist category; distinguish investigational company data from approved, peer-reviewed evidence |
| Adjustable IOL | Patients who can return for postoperative refinement and comply with instructions | Visit burden, UV compliance, adjustment and lock-in sequence |
How PrecisionIOL should be framed
The product should not say "the best IOL is X," especially when AI-assisted cataract tools remain uneven in complex and premium scenarios. A safer, more clinically useful output is: "this pathway is being surfaced because these measurements, history, goals, and workflow constraints fit; these are the tradeoffs; these are the verification steps before final planning."
Emerging designs like virtual-aperture optics should be handled as watchlist evidence until larger, controlled, peer-reviewed and regulatory-cleared data exist. PrecisionIOL can still make this clinically useful by tracking the dimensions that matter: near/intermediate range, mesopic acuity, halos, glare, contrast, patient goals, and approval status.
Premium counseling also needs a value conversation. Registry data can show how well routine cataract surgery performs at scale, while cost-limited access to advanced lenses reminds clinicians to document why a premium option adds value for this particular patient: astigmatism correction, intermediate range, spectacle independence, postoperative adjustability, or a lower-risk enhanced monofocal compromise.
That clinician-supervised explanation layer is the differentiator. Manufacturer tools can be excellent inside their ecosystems. PrecisionIOL can compete as the vendor-neutral layer that helps a surgeon unify inputs, counseling, preference, and documentation.
Use decision support inside the planner
Review lens fit, warnings, lifestyle scoring, and patient-facing counseling from the same case workflow.
Open IOL Planner